Effects of intravenously injected vitamin K1 and water-soluble vitamin K (menadione sodium bisulphite) on hypoprothrombinaemia during anticoagulation treatment.
D000925:Anticoagulants / Q000009:adverse effects*; D000933:Antifibrinolytic Agents; D006494:Heparin Antagonists; D006801:Humans; D007020:Hypoprothrombinemias; D009285:Naphthoquinones; D011516:Prothrombin; D014812:Vitamin K / Q000627:therapeutic use*; D010837:Vitamin K 1; D024483:Vitamin K 3; D014815:Vitamins
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D006494:Heparin Antagonists; D009285:Naphthoquinones; D014815:Vitamins; D014812:Vitamin K; D024483:Vitamin K 3; D010837:Vitamin K 1; D011516:Prothrombin
ANTICOAGULANTS/injurious effects; PROTHROMBIN/deficiency; VITAMIN K/therapeutic use